Futures
Access hundreds of perpetual contracts
CFD
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
CFD
U.S. stock CFD derivatives
US Stocks
Access real US stocks and ETFs
HK Stocks
Trade quality Hong Kong-listed stocks
Korean Stocks
SK Hynix
Real Korean stocks and top assets
Stock Futures
High leverage, 24/7 trading
Tokenized Stocks
Backed by real stock assets
IPO Access
Unlock full access to global stock IPOs
GUSD
Mint GUSD for Treasury RWA yields
Stocks Activities
Trade Popular Stocks and Unlock Generous Airdrops
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
IPO Access
Unlock full access to global stock IPOs
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Promotions
AI
Gate AI
Your all-in-one conversational AI partner
Gate AI Bot
Use Gate AI directly in your social App
GateClaw
Gate Blue Lobster, ready to go
Gate for AI Agent
AI infrastructure, Gate MCP, Skills, and CLI
Gate Skills Hub
10K+ Skills
From office tasks to trading, the all-in-one skill hub makes AI even more useful.
Alphabet Officially Joins the Dow. These 3 Dow Dividend Stocks Are Better Buys for July.
The Dow Jones Industrial Average looks different this month. Before trading opened on June 29, Alphabet (GOOGL 0.23%) (GOOG 0.37%) took Verizon Communications' (VZ +1.37%) seat in the 30-stock index, a move S&P Dow Jones Indices framed as a way to broaden the Dow's exposure to advertising, cloud computing, and artificial intelligence. It is a milestone for a company that once seemed too big and too tech-heavy for a benchmark first built in 1896.
There is a catch for income investors, though. Alphabet pays only a token dividend, and its yield is far below that of the Dow's established payers. For readers who care about getting paid to wait, three other Dow members look like more rewarding places to put money to work in July.
Expand
NASDAQ: GOOGL
Alphabet
Today's Change
(-0.23%) $-0.85
Current Price
$360.36
Key Data Points
Market Cap
$4.4T
Day's Range
$353.47 - $364.20
52wk Range
$172.77 - $408.61
Volume
1.1M
Avg Vol
31.5M
Gross Margin
60.43%
Dividend Yield
0.24%
The most interesting story in the Dow this summer belongs to Honeywell Technologies (HON +3.66%). On the same day Alphabet joined the index, Honeywell completed the spinoff of its aerospace arm and reinvented itself as a focused automation company. The old conglomerate split into three separate businesses: Honeywell Technologies, Honeywell Aerospace, and Solstice Advanced Materials.
Image source: Getty Images.
What remains is a company centered on factory automation, building controls, and energy systems, which is the plumbing behind modern industry. Breakups like this can unlock value that sat hidden inside a sprawling parent, since management gains the freedom to direct capital toward the parts growing fastest. Honeywell kept its dividend through the separation, which gives patient shareholders income while the market sorts out what the leaner business is worth. The risk is real: Spinoffs bring messy accounting and a stretch of uncertainty before the pieces find their footing.
Expand
NASDAQ: HON
Honeywell Technologies
Today's Change
(3.66%) $8.11
Current Price
$229.86
Key Data Points
Market Cap
$73B
Day's Range
$220.22 - $230.13
52wk Range
$195.77 - $260.15
Volume
5.7M
Avg Vol
2.6M
Gross Margin
38.06%
Dividend Yield
2.11%
Amgen (AMGN +3.58%) does not make headlines the way flashier biotech names do, yet it has built one of healthcare's steadier dividends. The company raised its payout by 6% for 2026, extending a long run of increases that has turned it into a favorite among income seekers.
The part that could reshape the story sits in its pipeline. Amgen is running a wide set of late-stage trials for MariTide, its monthly obesity treatment, spanning weight management, type 2 diabetes, and cardiovascular outcomes. The obesity market is enormous, and a once-a-month injection could stand apart from the weekly options that dominate today. Nothing is a sure thing in drug development, and a trial stumble would sting, but shareholders collect a growing dividend while that bet plays out. That combination of income today and optionality tomorrow is rare in a stock this large.
Expand
NASDAQ: AMGN
Amgen
Today's Change
(3.58%) $12.93
Current Price
$374.26
Key Data Points
Market Cap
$202B
Day's Range
$363.46 - $375.14
52wk Range
$269.77 - $391.29
Volume
109.3K
Avg Vol
2.8M
Gross Margin
71.51%
Dividend Yield
2.62%
Chevron (CVX +2.03%) has lifted its payout for decades without interruption, and it added another 4% increase for 2026. That consistency is the draw for conservative investors, but the more overlooked development is what the company bought.
Its acquisition of Hess, completed in 2025, handed Chevron a 30% stake in Guyana's Stabroek Block, one of the largest oil discoveries of the century. Output there keeps climbing as new offshore vessels come online, giving an old energy giant a rare source of low-cost growth. Oil prices remain the obvious wild card, and a sharp drop would pressure both profits and buybacks. Even so, few dividend payers this size can point to a growth story this concrete.
Expand
NYSE: CVX
Chevron
Today's Change
(2.03%) $3.37
Current Price
$169.06
Key Data Points
Market Cap
$337B
Day's Range
$167.65 - $169.54
52wk Range
$145.58 - $214.71
Volume
401.3K
Avg Vol
10.1M
Gross Margin
15.15%
Dividend Yield
4.13%
These are strong picks for July
Alphabet's arrival makes the Dow more modern, but modern does not always mean better for income. Honeywell Technologies offers a fresh start as a focused operator, Amgen offers a growing dividend with real upside, and Chevron offers reliability plus a Guyana catalyst that few peers can match. For investors who want a portfolio that pays them along the way, these three look like the better buys this month. As always, spreading money across all three, rather than chasing one, is the steadier path.